top of page

DU-145 Xenograft Model

Rincon Bio offers efficacy studies using the DU-145 Xenograft Model at our U.S.-based facilities, with direct access to the scientists conducting your study.

Model Type:
Xenograft
Organ:
Prostate
ATCC link (if available):
Derivation:
Brain metastasis of a 69yo prostate cancer patient
Mutations:
CDKN2A, RB1, STK11, TP53
NCI60:
Yes
Weeks from stratification to termination (average):
6

DU-145 Growth Curve

(Representative of studies performed at Rincon Bio)

Representative tumor growth curve for the DU-145 xenograft model from studies performed at Rincon Bio.

For more information on this model, including available control data, please Contact Us, or request a Quote below

bottom of page